Other OTC - Delayed Quote • USD
Bellerophon Therapeutics, Inc. (BLPH)
As of May 10 at 9:30 AM EDT. Market Open.
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
Performance Overview
Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is S&P 500
Return | BLPH | S&P 500 |
---|---|---|
YTD | +51.89% | +9.56% |
1-Year | -99.36% | +26.71% |
3-Year | -98.53% | +27.07% |